• 1. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 2. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 3. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 4. Enantiomorphic symmetry breaking in crystallization of molten sodium chlorate?
  Martin R. Ward,Gary W. Copeland,Andrew J. Alexander Chem. Commun., 2010,46, 7634-7636
• 5. Enantiomeric helical TiO2 nanofibers modulate different peptide assemblies and subsequent cellular behaviors?
  Xu Jie,Deng Xu,Weili Wei RSC Adv., 2019,9, 29149-29153

Introduction to 3-bromo-6-methylpyridine-2-carboxylic acid (CAS No. 779344-30-8)

3-bromo-6-methylpyridine-2-carboxylic acid, identified by the Chemical Abstracts Service (CAS) number 779344-30-8, is a significant intermediate in the realm of organic synthesis and pharmaceutical development. This compound belongs to the pyridine derivatives, a class of heterocyclic aromatic compounds that have garnered considerable attention due to their diverse biological activities and synthetic utility. The presence of both bromine and carboxylic acid functional groups in its molecular structure makes it a versatile building block for further chemical modifications, enabling the construction of more complex molecules with tailored properties.

The molecular structure of 3-bromo-6-methylpyridine-2-carboxylic acid consists of a pyridine ring substituted with a bromine atom at the 3-position and a methyl group at the 6-position, while the 2-position is terminated by a carboxylic acid group. This specific arrangement of functional groups imparts unique reactivity, making it a valuable precursor in the synthesis of various pharmacologically active compounds. The bromine atom, in particular, serves as a handle for further functionalization via cross-coupling reactions such as Suzuki-Miyaura, Stille, or Buchwald-Hartwig couplings, which are widely employed in drug discovery and medicinal chemistry.

In recent years, 3-bromo-6-methylpyridine-2-carboxylic acid has found applications in the development of novel therapeutic agents. Its derivatives have been explored as potential inhibitors of enzymes and receptors involved in inflammatory pathways, cancer metabolism, and neurodegenerative diseases. For instance, studies have demonstrated its utility in synthesizing small-molecule modulators of Janus kinases (JAKs), which play a crucial role in immune responses and signal transduction. The carboxylic acid moiety allows for further derivatization into esters or amides, expanding its synthetic potential for creating prodrugs or enhancing solubility.

The pharmaceutical industry has leveraged 3-bromo-6-methylpyridine-2-carboxylic acid to develop compounds with anti-inflammatory and immunomodulatory effects. Researchers have reported its incorporation into molecules targeting interleukin-1β (IL-1β) signaling pathways, which are implicated in chronic inflammatory conditions such as rheumatoid arthritis and Crohn's disease. Additionally, its structural framework has been utilized in designing kinase inhibitors for oncology applications. The brominated pyridine core is particularly advantageous for generating libraries of compounds suitable for high-throughput screening (HTS), enabling rapid identification of lead candidates.

From an academic perspective, 3-bromo-6-methylpyridine-2-carboxylic acid serves as a model compound for studying electronic effects and steric influences in substituted pyridines. Its reactivity patterns have been thoroughly investigated in terms of nucleophilic aromatic substitution (SNAr) and electrophilic aromatic substitution (EAS), providing insights into how substituents modulate reaction outcomes. These mechanistic studies not only enhance our understanding of fundamental organic chemistry principles but also inform the rational design of synthetic strategies for complex molecules.

The synthesis of 3-bromo-6-methylpyridine-2-carboxylic acid typically involves multi-step organic transformations starting from commercially available precursors such as 6-methylpyridine. Common synthetic routes include bromination followed by carboxylation at the 2-position. Advanced techniques such as palladium-catalyzed cross-coupling reactions have also been employed to introduce additional substituents with high regioselectivity. The efficiency and scalability of these synthetic protocols are critical considerations for industrial applications, where cost-effectiveness and reproducibility are paramount.

Recent advances in computational chemistry have further accelerated the utilization of 3-bromo-6-methylpyridine-2-carboxylic acid in drug discovery. Molecular modeling studies have predicted its interactions with biological targets, aiding in the optimization of lead structures before experimental validation. This interdisciplinary approach combines experimental organic synthesis with computational methods to streamline the development pipeline from intermediate discovery to final drug candidates.

The versatility of 3-bromo-6-methylpyridine-2-carboxylic acid extends beyond pharmaceutical applications into materials science and agrochemicals. For example, its derivatives have been explored as ligands in coordination chemistry, where they form complexes with transition metals for catalytic purposes. In agrochemical research, modified pyridines derived from this compound have shown promise as herbicides or fungicides due to their ability to disrupt essential enzymatic pathways in pests.

In conclusion,3-bromo-6-methylpyridine-2-carboxylic acid (CAS No. 779344-30-8) is a multifaceted compound with broad utility across multiple scientific disciplines. Its role as an intermediate in pharmaceutical synthesis underscores its importance in modern drug development efforts aimed at addressing unmet medical needs. As research continues to uncover new applications and synthetic methodologies,3-bromo-6-methylpyridine-2-carboxylic acid will likely remain a cornerstone molecule in both academic laboratories and industrial settings.

• 53636-56-9(methyl 3-bromopyridine-2-carboxylate)
• 61830-12-4(2,6-Pyridinedicarboxylic acid, 3,5-dibromo-)
• 61830-40-8(3,5-Dibromopicolinic acid)
• 1189933-55-8(3-Bromopicolinic Acid Sodium Salt)
• 30683-23-9(3-Bromopyridine-2-carboxylic acid)
• 61830-10-2(2,6-Pyridinedicarboxylic acid, 3,5-dibromo-, dimethyl ester)
• 316808-11-4(Dimethyl 3-bromopyridine-2,6-dicarboxylate)
• 30766-11-1(5-bromopyridine-2-carboxylic acid)
• 909711-99-5(LITHIUM 5-BROMO-PYRIDINE-2-CARBOXYLATE)
• 316808-10-3(3-Bromopyridine-2,6-dicarboxylic acid)